Document is current
Any future updates will be listed below
-
Authors
Chang, Xuyao
Li, Wenqi
Matsui, Satoshi
Huynh, Cindy https://orcid.org/0000-0001-8487-3076
Erickson, Craig
Guo, Feng https://orcid.org/0000-0001-9103-3235
Cederquist, Gustav Y.
Studer, Lorenz https://orcid.org/0000-0003-0741-7987
Iwafuchi, Makiko https://orcid.org/0000-0003-1291-6246
Shillington, Amelle
Chronis, Constantinos
Tchieu, Jason https://orcid.org/0000-0002-9793-9836
-
Funding
Funding for this research was provided by:
Cincinnati Children's Research Foundation
U.S. Department of Defense (W81XWH-22-1-0533)
Starr Foundation (Tri-SCI-2023-013)
Memorial Sloan-Kettering Cancer Center (P30CA008748)
U.S. Department of Health & Human Services | National Institutes of Health (R01GM143161)
- License Information
-
More Information
Article History
Received: 22 November 2024
Accepted: 8 September 2025
First Online: 9 October 2025
Competing interests
: LS is a co-founder and consultant of BlueRock Therapeutics and DaCapo BrainSciences, which represent financial competing interests. The remaining authors declare that they have no competing financial or non-financial interests.
